Koselugo is proven to reduce the size of plexiform neurofibromas (PN).*
*66% or 33 of 50 patients in the clinical study saw a 20% or more decrease in the size of their plexiform neurofibromas, confirmed by 3D magnetic resonance imaging scan.
For personalized Koselugo support, call 1-888-765-4747 or visit www.AlexionOneSource.com.